Whether these polymorphisms may represent genetic risk factors to male reproductive disorders apart from fertility, but possibly affected by impaired FSH action (e.g. cryptorchidism, hypospadias, testicular dysgenesis syndrome and testicular cancer), has to be addressed in future studies. The gene discussed is BRD2; the disease is cryptorchidism.